A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).

Por um escritor misterioso
Last updated 30 setembro 2024
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Treat-to-target in axial spondyloarthritis — what about physical function and activity?
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Recommendations for the management and treatment of ankylosing spondylitis – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
These highlights do not include all the information needed to use CYLTEZO safely and effectively. See full prescribing information for CYLTEZO. CYLTEZO® (adalimumab-adbm) injection, for subcutaneous use Initial U.S. Approval: 2017 CYLTEZO (
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial, Trials
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Full article: The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
TNF Inhibitor Therapy, Ankylosing Spondylitis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Poster Abstract Presentation Abstracts - 2023 - International Journal of Rheumatic Diseases - Wiley Online Library
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019, Advances in Rheumatology
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).

© 2014-2024 atsrb.gos.pk. All rights reserved.